Major Rating Factors:
Poor long-term capitalization index (0.2 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (2.1) that places pressure on both capital and profits. The one year reserve development was deficient in three of the last five years by between 27.3% and 45.1%. Weak profitability index (2.9) with operating losses during 2022, 2024 and 2025.
Other Rating Factors:
Weak overall results on stability tests (2.2) including weak results on operational trends, weak risk diversification and excessive premium growth. The largest net exposure for one risk is excessive at 6.8% of capital. Excellent liquidity (7.3) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
G - Fast asset or premium growth.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
NC
Principal Investments:
Investment grade bonds (68.1%), cash (9.9%), other (22.0%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
1605 Main Street
Sarasota, FL 34236
Sarasota, FL 34236
Phone Number
(800) 226-0793
NAIC Number
16383
Website
Largest Affiliates
There are no affiliate to display.